Page results
-
UCLH vision, values and strategy
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
Patient information on managing pain
-
Health and wellbeing information for people affected by cancer.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
File results
-
FOI/2024/0561 - Gender reassignment and/or transgender policies, mixed/same sex accommodation and Equality Impact Assessments (EIA)
-
FOI/2024/0560 - Coroners' Prevention of Future Deaths Reports
-
FOI/2024/0559 - Surgical Robots purchase/ simulators/ procedures 2019-2024
-
FOI/2024/0455 - Information Governance structure
-
FOI/2024/0541 - Healthcare-associated infections (HAIs) 2022-2024
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0534 - NHS staff absence rates
-
FOI/2024/0542 - Single-use medical items usage at Trust
-
FOI/2024/0450 - Trust-wide obesity and weight management strategy
-
FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology